People · Operator
Named in public records as an officer, director or promoter · active 2010–2013 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Decimmune Therapeutics Inc | — | Other Health Care | Seed | $2.8M | $43.4M | 2010 |
Richard S. Foemmel, Ph.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard S. Foemmel, Ph.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Harold R. Werner | 1 | 4 |
| Lewis J Geffen | 1 | 2 |
| Christopher K. Mirabelli, Ph.D. | 1 | 1 |
| Michael C. Carroll, Ph.D. | 1 | 1 |
| Janis C. Naeve, Ph.D. | 1 | 1 |
| Lewis K. Geffen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.